Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...

Soft tissue sarcomas rarely metastasize to the heart, with cardiac involvement seen in less than 0.03% of cases. Metastatic heart disease presents diagnostic challenges due to nonspecific symptoms, ...

A new Brazilian study has revealed the key role of the protein periostin and stellate pancreatic cells in allowing pancreatic ...

Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Highlighting the urgent need for awareness and support for sarcoma, a rarely discussed but serious cancer affecting many.